Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mapi Pharma Ltd.

www.mapi-pharma.com

Latest From Mapi Pharma Ltd.

Finance Watch: VC Investment Soars In Q1, Putting Biopharma On Track For A Record Year

Pharma and biotech companies raised $4.6bn in the first quarter, exceeding the 2017 quarterly average by $1.4bn. But while the money invested soared, the number of companies funded sank. In public financings, MorphoSys commences US IPO and Mylan sells $1.5bn in notes.

Deals Financing

Mylan Poised To Launch Its First US Biosimilar, With A Stacked Pipeline Behind It

A biosimilar of Amgen's Neulasta appears on track for FDA approval by the June 4 action date, management said during an investor briefing that showcased Mylan's expansive biosimilar pipeline. Mid- to late-stage copies of products like Advair, Symbicort, Herceptin, Humira, Avastin, Rituxan, Eylea and Botox highlight the strategic direction Mylan moved in nearly a decade ago. 

Biosimilars Generic Drugs

Mylan Poised To Launch Its First US Biosimilar, With A Stacked Pipeline Behind It

A biosimilar of Amgen's Neulasta appears on track for FDA approval by the June 4 action date, management said during an investor briefing that showcased Mylan's expansive biosimilar pipeline. Mid- to late-stage copies of products like Advair, Symbicort, Herceptin, Humira, Avastin, Rituxan, Eylea and Botox highlight the strategic direction Mylan moved in nearly a decade ago. 

Biosimilars Generic Drugs

Pipeline Watch: Phase III Starts For Molidustat, Tecentriq And Tislelizumab

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Drug Delivery
    • Generic Drugs
  • Therapeutic Areas
  • Immune Disorders
  • Neurology, Nervous System
  • Alias(es)
  • Mapi - Pharma Ltd.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Middle East
      • Israel
  • Parent & Subsidiaries
  • Mapi Pharma Ltd.
  • Senior Management
  • Ehud Marom, CEO
    Nir Bernstein, CFO
    Shai Rubnov, PhD, VP, R&D
    Alex Mogle, VP, Corp. Dev.
    Safi Landskroner , VP, Bus. Dev. & Reg. Affairs
  • Contact Info
  • Mapi Pharma Ltd.
    Phone: 73 7121213
    Weizmann Science Pk.
    16 Einstein St.
    P.O. Box 4113 Ness Ziona, 74140
    Israel
Advertisement
Advertisement
UsernamePublicRestriction

Register